Universe Pharmaceuticals (UPC) Cash & Current Investments (2020 - 2025)
Historic Cash & Current Investments for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $33.6 billion.
- Universe Pharmaceuticals' Cash & Current Investments rose 40414.86% to $33.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $33.6 billion, marking a year-over-year increase of 40414.86%. This contributed to the annual value of $29.5 billion for FY2025, which is 34270.09% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Cash & Current Investments stood at $33.6 billion for Q3 2025, which was up 40414.86% from $6.7 billion recorded in Q3 2024.
- Over the past 5 years, Universe Pharmaceuticals' Cash & Current Investments peaked at $33.6 billion during Q3 2025, and registered a low of $1.4 million during Q3 2023.
- In the last 5 years, Universe Pharmaceuticals' Cash & Current Investments had a median value of $27.4 million in 2022 and averaged $5.8 billion.
- Per our database at Business Quant, Universe Pharmaceuticals' Cash & Current Investments tumbled by 9997.6% in 2023 and then skyrocketed by 48528005.3% in 2024.
- Quarter analysis of 5 years shows Universe Pharmaceuticals' Cash & Current Investments stood at $21.8 million in 2021, then soared by 26155.92% to $5.7 billion in 2022, then tumbled by 99.98% to $1.4 million in 2023, then soared by 485280.05% to $6.7 billion in 2024, then skyrocketed by 404.15% to $33.6 billion in 2025.
- Its last three reported values are $33.6 billion in Q3 2025, $6.7 billion for Q3 2024, and $7.8 million during Q1 2024.